Get startedLog in
    Picture of Kezar Life Sciences logo

    KZR — Kezar Life Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    All News

    Brief: Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition Of Preclinical Assets From Kezar Life Sciences

    Picture of Kezar Life Sciences logoKezar Life Sciences
    12/03/2026 13:15
    March 12 (Reuters) - Enodia Therapeutics:

ENODIA THERAPEUTICS STRENGTHENS SEC61 PORTFOLIO THROUGH ACQUISITION OF PRECLINICAL ASSETS FROM KEZAR LIFE SCIENCES

ENODIA THERAPEUTICS - KEZAR TO RECEIVE $1 MILLION UPFRONT AND UP TO $127 MILLION IN MILESTONE PAYMENTS

Further company coverage: KZR.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kezar Life Sciences

    See all news